Akribion
A new class of cancer therapies using RNA-guided nucleases for specific cell depletion
Akribion has raised €8.0M across 1 funding round from 6 investors, most recently a Seed round in Feb 2025. Based in Zwingenberg, Germany; active in Healthtech. Data as of 28 Oct 2026.
Zwingenberg, Germanyakribion-therapeutics.com ↗
Total raised
€8.0M
€8,000,000
Funding rounds
1
Investors
6
distinct backers
Active since
2025-02
latest 2025-02
Funding by year
EUR raised per yearAkribion — funding by year — interactive chart.
Data table
| Akribion — funding by year | |
|---|---|
| 2025 | €8.0M |
Signals
High confidenceRaise-next likelihood43
base rate 44% for Seed
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-02-04 | Seed | €8.0M | Carma Fund,Bruker Invest,Hessen Kapital I,High-Tech Gründerfonds (HTGF),MP Beteiligungs GmbH,RV Invest | View deal → |
Investors
6Related news
Similar companies
same sector or country- Delivery Hero€7.1BGermany · E-commerce
- Enpal€4.6BGermany · Cleantech
- Auxmoney€3.5BGermany · Fintech
- Helsing€2.9BGermany · AI
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
Global coverage: FundingData